NPS Member Update

18 April 2008

In this issue

 

1.      National Medicines Symposium

2.      NPS Facilitators' Forum

3.      Common colds campaign 2008

4.      2020 QUM

5.      Consumers want to hear from HPs about their complementary medicines

6.      Introducing the latest Pharmacy Practice Review

7.      NPS News: Focus on chronic heart failure

8.      MedicinesTalk: Medicines and your money

9.      Medicine Update

10.  Australian Prescriber

11.  NPS RADAR

12.  Member organisation contribution: Rural health project grants

 

 

1.      National Medicines Symposium

 

The National Medicines Symposium for 2008 is less than one month away and the final program will stimulate much discussion and debate among delegates.

 

Four international speakers will cover topics on QUM and the ageing world; medicines, consumers and society; and QUM and the political economy. Over 350 delegates from more than 11 countries have already registered for this event .

NMS 2008 will be a great event for networking with new contacts from across the health spectrum. If you have not already registered, visit the NPS website at www.nps.org.au and click on the NMS banner.

 

2.      NPS Facilitators' Forum

 

More than 90 NPS Facilitators representing internationally acknowledged, best practice QUM educators from every Australian State and Territory have registered for the annual Facilitators' Forum, to be held in Canberra on May 14.

 

The theme for this year is Leading the QUM challenge: integrity, balance and excellence in recognition of the pioneering efforts of NPS Facilitators, who are at the forefront of QUM in Australia, and the three key principles that guide their approach to their work.

 

A thought-provoking program has been developed, featuring international speakers (who are also attending the National Medicines Symposium), as well as Australian leaders in a variety of relevant fields.

 

Plenary topics will include a presentation and open forum on navigating for successful outcomes, as well as an interactive session on influencing others while maintaining your balance. There will be five concurrent workshops on offer for delegates, ranging from interpreting clinical information and presenting evidence, to overcoming cognitive dissonance, developing useful relationships with local media, and a 'how-to' on writing abstracts and developing posters for clinical and scientific events.

 

3.      Common Colds campaign 2008

 

NPS is now gearing up for its annual Common colds need common sense, not antibiotics health campaign. This year's campaign will run in two phases. Phase 1 will launch in late May and focus on hygiene messages, while phase 2 will launch in August and focus on antibiotics messages (August is a peak month for antibiotic prescriptions). NPS is currently updating recommendations for over-the-counter medicines and complementary medicines.

 

Target audiences include:

·         Parents of young children

·         Childcare centre staff (more than 500 centres have nominated to receive a presentation from a health professional or will conduct a presentation provided by NPS)

·         School communities (to reach parents of primary-school-aged children)

·         Women aged 18-34, who have been observed to have less desirable attitudes to using antibiotics for colds.

 

NPS will partner with Ross and Julia Ross recruitment services for the second consecutive year as part of its efforts to expand the Common colds campaign into Australian workplaces.

 

The 2008 Common colds need common sense, not antibiotics website will soon be live: keep watching the NPS website for updates.

 

4.      2020 QUM

 

NPS has prepared a QUM submission for the long-term national health strategy discussion at the April 2020 Summit. Issues of policy, cost-effectiveness, access to information and technology are critical to Australia's vision of a future national health system.

 

The submission will become accessible online at www.australia2020.gov.au

 

5.      Consumers want to hear from HPs about their complementary medicines

 

Preliminary results from NPS research are showing that most consumers ask friends and family when it comes to complementary medicines, while in fact they would prefer to get this information from their doctor or pharmacist. In addition, seeking information about complementary medicines on the internet has become common practice among consumers.

 

At the International Congress on Complementary Medicine Research in Sydney, NPS recently presented the preliminary results of a research initiative to understand what information consumers of complementary medicines want and how they prefer to access this information. The research report will be finalised in August. The results will facilitate the development of improved and accessible information sources and educational strategies that will ultimately enhance consumer knowledge and improve their decisions and behaviour around use of complementary medicines.

 

More information about further research on complementary medicines is available on our website.

 

6.      Introducing the latest Pharmacy Practice Review

 

Enrolments are now open for 'Enhancing patient care in type 2 diabetes' - the latest Pharmacy Practice Review - a counselling and action resource.

 

This review aims to assist pharmacists in managing patients with a diagnosis of type 2 diabetes, using an antidiabetic agent(s).

 

Pharmacy Practice Reviews use best practice standards and guidelines to help pharmacists review current practice, consider implementing changes to practice, review and reflect on these changes and monitor progress. The materials also focus on identifying priorities for patient counselling, provide tools to assist effective counselling and identify pharmacist competencies, which will be addressed by completion of the activity.

 

All participants receive a feedback report that includes individual results, aggregate results of all participants' practices and an expert commentary on those aggregate results.

 

Pharmacists can enrol now either online or via an enrolment form to receive the Pharmacy Practice Review materials in May. This program is recognised for Continuing Professional Development points by several NPS member organisations.

 

Details: https://www.nps.org.au/resources/content/PPR_enrol_type2diabetes.php

 

7.      NPS News: Focus on chronic heart failure

 

NPS News 57 (April 2008) is titled Improving outcomes in chronic heart failure.

 

Chronic heart failure is a progressive disease mostly affecting people aged over 65 and the prevalence increases sharply with age.

 

This issue of NPS News highlights the importance of early detection and patient support to maximise the benefits of drug therapies at all stages of chronic heart failure. Topics include targeted education and multidisciplinary support, use of ACE inhibitors as first-line therapy for chronic heart failure, and use of heart-failure-specific beta blockers in all stabilised patients.

 

NPS News 57 also includes Case Study 52: Optimising chronic heart failure therapy for GPs, pharmacists, nurses and other health professionals.

 

These NPS materials form part of a joint program with the National Heart Foundation of Australia and the NHMRC National Institute of Clinical Studies to improve the management of heart failure.

 

8.      MedicinesTalk: Medicines and your money

 

Medicines can swallow a substantial chunk of the family budget, so the Autumn 2008 issue of the NPS consumer publication, MedicinesTalk, provides some excellent tips on how to reduce spending on medicines without compromising your health.

 

Recommendations include having your medicines reviewed, considering generic medicines and asking about a different strength medicine. Consumers are also urged to understand the Safety Net and authority prescriptions. This issue includes useful information about the potential for medicine interactions, new medicines and Medicines Line - which provides independent information for consumers by qualified pharmacists at the cost of a local call.

 

Read MedicinesTalk online or visit the NPS website to order one or more hard copies.

 

9.      Medicine Update

 

The latest issue of Medicine Update reviews strontium ranelate (Protos), a medicine used to treat osteoporosis, or fragile bones. It can be used by women who have already had a fracture due to osteoporosis and by those who have not, but are at high risk.

 

Medicine Update is an NPS publication that helps to answer some of the questions commonly asked about medicines when they first become available through the PBS.

Medicine Update gives important information about how to use the medicine, as well as how it compares with other medicines for osteoporosis. If this topic is relevant to your membership, we would be happy to provide a copy in PDF format for uploading to your website.

 

10.  Australian Prescriber

 

This month, Australian Prescriber presents the following articles:

·         Compounding in community pharmacy

·         The role of drugs in road safety

·         Treatment of perinatal depression - and patient support information for perinatal depression

·         Ear drops and ototoxicity.

 

Additional features include:

·         Book review of Therapeutic Guidelines: Analgesic

·         Abnormal laboratory results: Therapeutic drug monitoring - which drugs, why, when and how to do it

·         Corticosteroid-induced osteoporosis and fractures

·         New drug reviews on: lenalidomide, nilotinib, paliperidone, raltegravir, rotigotine, sitagliptin

 

Australian Prescriber can be read online at www.australianprescribercom.au

 

11.  NPS RADAR

 

New drugs reviewed in-depth in the April issue of NPS RADAR are fentanyl lozenges (Actiq), an oromucosal formulation for the control of breakthrough cancer pain, and paliperidone (Invega) for people with schizophrenia.

 

The first review notes when fentanyl lozenges are to be used and asks doctors and pharmacists to be aware of important safety issues.

 

Paliperidone is the major active metabolite of risperidone. In its review, NPS RADAR states that the clinical response to paliperidone is likely to be similar to that of risperidone, but there are no comparative data.

 

The April print issue includes an update on the extended PBS listing for pioglitazone (Actos) in the treatment of type 2 diabetes and the review of varenicline (Champix) for smoking cessation, which was published on the NPS RADAR website (www.npsradar.org.au) in January.

 

This issue also carries brief reviews of:

·         Methylphenidate (Ritalin LA), a second long-acting formulation PBS listed for attention deficit hyperactivity disorder

·         Smaller syringe volume influenza vaccine PBS listed for children aged 6-35 months

·         Terbinafine cream and tablets for fungal infections in Aboriginal and Torres Strait Islander peoples.

 

12.  Member organisation contribution: Rural health project grants

 

Rural community project grants are currently available to develop and support community-run healthcare programs in rural and remote areas. Grants of up to $20 000 are available for community projects (which are no longer than 12 months in duration and must be completed by 31 March 2010) that integrate the support of local community pharmacy.

 

The Small Project Funding Scheme is an initiative of the Rural Pharmacy Workforce Program (RPWP), which is funded by the Australian Government Department of Health and Ageing and managed by the Pharmacy Guild of Australia. The scheme aims to support community healthcare in rural and remote communities so that innovative ideas and services can be developed and implemented.

 

All projects must be completed by 31 March 2010.

 

To be eligible projects are required to meet the following criteria:

·         Demonstrate the capacity to provide ongoing benefits to the community after completion of the program

·         Must involve a pharmacist or pharmacy-related organisation in the proposal

·         Applicants must be Australian citizens.

 

The closing date for applications is 5pm Friday, 2 May 2008.

 

Interested persons or groups should contact:

Ms Michelle Quester

Program Manager, Rural Pharmacy Workforce Program

Pharmacy Guild Australia

PO Box 7036

Canberra Mail Centre ACT 2600

 

Phone: (02) 6270 1888

Email: michelle.quester@guild.org.au

 

More information and application forms are also available at the RPWP website, www.ruralpharmacy.com.au

 

 

Does our website meet your needs? Complete our two minute survey.